Home > Browse Research > Life Sciences > Biotechnology > Biologics

Biologics: market research reports

A biologic medical product or a biologic or biological, is a medicinal product such as a vaccine, blood or blood component, gene therapy, tissue, recombinant therapeutic protein, or living cells that are used as therapeutics to treat diseases. Biologics are created by biologic processes, rather than being chemically synthesized. Biologics can be composed of sugars, proteins, or nucleic acids or a complex combination of these substances.
They may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources that can be human, animal, or microorganism.

Biologics market research reports and industry analysis

Biologic Imaging Reagents: Technologies and Global Markets 1/1/2013 \| published by: BCC Research ... from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 Coverage of fluorescent probes and dyes; imaging nanomaterials (including quantum dots and other nanoparticles); fluorescent proteins; supermolecules; contrast reagents for ... \| more...	$5,450.00
Biologic Therapeutic Drugs: Technologies and Global Markets 1/1/2013 \| published by: BCC Research ... Coverage of large market segments such as monoclonal antibodies (mAb), therapeutic proteins, and vaccines Examination of the competitive environment with a special focus on how new products and technologies are influencing the current standard of ... \| more...	$5,450.00
Innovation in the Prefilled Syringe Market - Biologics and Autoinjection Devices Shaping Future R&D Trends 12/14/2012 \| published by: GBI Research ... Biologics and Autoinjection Devices Shaping Future R&D Trends”, which provides insights into possible future avenues of R&D in the prefilled syringe market. This includes an overview of problems and possible solutions, as well as discussion ... \| more... Search inside this report	$3,500.00
Hernia Repair Device Markets and Procedures 11/6/2012 \| published by: Kalorama Information ... are consistent from year to year. This report, Hernia Repair Device Markets and Procedures looks at the hernia repair industry segment. New product innovation, a steady demand for superior products by surgeons, and increasing procedure ... \| more... Search inside this report	$3,995.00
Biologicals in Oncology Drug Pipeline Update 2012 10/16/2012 \| published by: BioSeeker Group AB ... in cancer. In addition, there are 24 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 858 drugs. Biologicals In Oncology Drug Pipeline Update lists all drugs and ... \| more...	$2,279.00
Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment 10/15/2012 \| published by: GBI Research ... - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment”. The report provides insights into the dermatology therapeutics market including market forecasts up to 2018. It provides an in-depth analysis of the major ... \| more... Search inside this report	$3,500.00
Biologics in the Emerging Markets – Ripe for Realization of the Commercial Potential – But Hurdles Still to Overcome 9/1/2012 \| published by: CBR Pharma Insights, LLC ... many less developed healthcare markets. However, the global biologics market is rapidly growing and was estimated to be worth over $130 billion in 2010. Of the emerging markets, the BRIC markets offer the greatest potential ... \| more... Search inside this report	$3,900.00
Spinal Devices and Biologics Market in the US 2011-2015 8/27/2012 \| published by: Infiniti Research Limited ... the development of better and longer-lasting implants. The Spinal Devices and Biologics market in the US has also been witnessing increasing popularity of minimally invasive surgery. However, the reduction in reimbursements for spinal procedures could ... \| more... Search inside this report	$1,500.00
Global Biopharmaceuticals Market 2011-2015 7/5/2012 \| published by: Infiniti Research Limited ... technologies. The Global Biopharmaceuticals market has also been witnessing the trend of an increase in RandD activities. However, patent expiration of top-selling drugs could pose a challenge to the growth of this market. TechNavio's report, ... \| more... Search inside this report	$2,000.00
Rheumatoid Arthritis Pipeline Perspectives Report - Direct Inflammatory Cytokine Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$2,250.00
Rheumatoid Arthritis Pipeline Perspectives Report - T-cell Activation Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - Intracellular Signaling Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - Non-Lymphocytic Inflammatory Cell Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013 7/1/2012 \| published by: Barnett Educational Services ... provides the latest market intelligence on every aspect of biopharmaceutical development – from product discovery, to R&D performance and productivity, to time-to-market trends. With key analysis and contributions from leading consultancies and experts, the Sourcebook ... \| more...	$425.00
Top 200 Biopharmaceutical Companies (Global) 7/1/2012 \| published by: Plimsoll Publishing Ltd. ... to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: 85 of ... \| more...	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - Inflammatory Cytokine Production Inhibitors 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - T-cell Migration Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Rheumatoid Arthritis Pipeline Perspectives Report - B-cell Blockers 7/1/2012 \| published by: Pharmspective ... to explore opportunities to enter this category. Rheumatoid Arthritis Pipeline Perspectives Reports provide a comprehensive assessment of the drugs in development for RA by pathway target and mechanism of action. Pipeline Analysis by Pathway Target ... \| more... Search inside this report	$1,500.00
Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes 3/14/2012 \| published by: GBI Research ... Recalls than Other Drug Classes”, provides in-depth analysis of biologics recalls issued or reported with the US Food and Drug Administration (FDA) and its constituent agencies. The report analyzes biologics recalls on the basis of ... \| more... Search inside this report	$3,500.00
The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment 3/1/2012 \| published by: Ken Research ... as market size of the pharmaceutical industry, market segmentation by Branded and Generic drugs, and Prescribed and OTC drugs and Biologics and specialty drugs segments. The report also provides information on the government regulations, export ... \| more... Search inside this report	$595.00
Biologicals in Oncology Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... cancer. In addition, there are 17 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 676 drugs. Biologicals In Oncology Drug Pipeline Update lists all drugs and gives ... \| more...	$3,749.00
Product Profiles: Disease Modification in Rheumatoid Arthritis – Game-changing therapy close to market 1/19/2012 \| published by: Datamonitor ... also saw lifecycle management strategies in effect with the launch of a reformulation of Orencia and a strong marketing move to revise the US drug label of Actemra. Features and benefits Access Datamonitor’s independent appraisal ... \| more... Search inside this report	$11,400.00
Market and Product Forecasts: Psoriasis – Novel products and current biologics to fuel future market growth 11/30/2011 \| published by: MarketLine ... is trailblazing the US and EU markets, threatening both brands. By 2020, biosimilars, generics and four product launches will grow the market to $5.5bn. Features and benefits Access Datamonitor’s patient based psoriasis market forecast of ... \| more...	$11,400.00
Product Profiles: Psoriasis – Novel therapies raise the bar for biologics 11/23/2011 \| published by: Datamonitor ... regulatory filings of Ozespa (briakinumab), a key contender to Stelara in early 2011, this leaves Stelara to continue its ascendance across the seven major markets. Features and benefits Gain insight into how new market entrants ... \| more... Search inside this report	$11,400.00
Market and Product Forecasts: Disease Modification in Rheumatoid Arthritis – Novel therapies plus reformulations poised to enter the market 9/8/2011 \| published by: MarketLine ... remain dominant market players, but the growing enthusiasm for non-TNF biologics at earlier lines of therapy is predicted to continue over the next decade and serves as an additional growth driver. Features and benefits Gain ... \| more...	$11,400.00

< prev 1 2 next >

Research assistance

Matching geography

Start new browse

Join Alert Me now!

Biologics: market research reports

Biologics market research reports and industry analysis